Bahrain vs Cape Verde: The number of people with susceptibility test result for rifampicin
Bahrain
112
in 2021
Cape Verde
98
in 2021
Bahrain rank
107th
Cape Verde rank
110th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Cape Verde
How they compare
Bahrain currently reports 112 against 98 in Cape Verde, a difference of 14.
That makes Bahrain's figure about 1.1 times Cape Verde's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bahrain ahead.
Bahrain ranks 107th and Cape Verde ranks 110th of 155 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84 | 82.33 | 1.67 | Bahrain |
| 2020s | 97 | 87.5 | 9.5 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Cape Verde?
- Bahrain, at 112 against 98 in Cape Verde as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Cape Verde?
- 14, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Cape Verde?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Cape Verde rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 107th and Cape Verde ranks 110th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.